NABR: New review of long-tailed macaque population recommends two steps for accurate reassessment of long-tailed macaque global population

NABR: New review of long-tailed macaque population recommends two steps for accurate reassessment of long-tailed macaque global population

WASHINGTON, Oct. 29, 2025 /PRNewswire/ -- A recent article published in the American Journal of Primatology criticizes work relied upon by the International Union for Conservation of Nature (IUCN) in its latest determination concerning long-tailed...

Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial

Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial

Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across Korea and the U.S. Interim baseline characteristics to be presented at the 2025 KATRD...

UOB Asset Management anticipates a greater focus on Asian markets in 3Q 2025

UOB Asset Management anticipates a greater focus on Asian markets in 3Q 2025

SINGAPORE, June 24, 2025 /PRNewswire/ -- In its 3Q 2025 Quarterly Investment Strategy to be published this week, UOB Asset Management (UOBAM) highlights the almost equal probability of three US economic scenarios: a US recession, continued growth,...

England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy

England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy

First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure 1-3 NICE's recommendation is based on clinically meaningful results from the phase-III PROTECT trial 4...

menu
menu